≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Use of interferon beta-1a

Endpoint Browser

MSMED_INTERFERONBETA1A

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Medicine purchases: ATC — L03AB07

1 out of 7 registries used, show all original rules.

893

4. Check minimum number of events

Min. number of events 3
893

5. Include endpoints

None

893

6. Filter based on genotype QC (FinnGen only)

893

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 893 710 183
Unadjusted period prevalence (%) 0.21 0.24 0.08
Median age at first event (years) 36.20 36.06 36.78

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
799
Matched controls
7991
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
32.9
323.0
464
322
109
Kela drug reimbursment
Multiple sclerosis
8591.5
323.0
768
30
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
5037.0
323.0
762
25
L03AB07
ATC
interferon beta-1a; parenteral
+∞
323.0
799
*
G35
ICD-10 Finland
Multiple sclerosis
+∞
323.0
799
48
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
2186.5
323.0
698
25
L03AX13
ATC
glatiramer acetate; parenteral
336.4
323.0
310
15
H46
ICD-10 Finland
Optic neuritis
137.9
283.0
291
33
N86
ICPC
Multiple sclerosis
314.4
281.4
271
13
164
Kela drug reimbursment
Fingolimod
550.4
217.9
207
5
N04BB01
ATC
amantadine; oral
100.4
214.0
230
32
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
112.0
213.1
226
28
L04AA31
ATC
teriflunomide; oral
470.2
191.6
184
5
353
Kela drug reimbursment
Cladribine and fingolimod
553.5
182.9
175
*
L04AX07
ATC
dimethyl fumarate; oral
233.4
181.5
181
10
L04AA27
ATC
fingolimod; oral
442.4
178.0
172
5
N07XX09
ATC
[U] dimethyl fumarate; oral
415.5
169.1
164
5
L03AB08
ATC
interferon beta-1b; parenteral
223.3
129.9
131
7
TAB00
NOMESCO Finland
Lumbar puncture
15.3
122.8
215
188
M03BX01
ATC
baclofen; systemic
43.3
119.9
149
42
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
27.1
107.9
151
68
XA800
NOMESCO Finland
Neuropsychological investigation
14.8
93.7
164
137
XCK00
NOMESCO Finland
Perimetry
12.9
92.4
173
168
G04BD09
ATC
trospium; oral
35.6
91.8
119
39
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
35.5
83.3
108
35
G04BD12
ATC
mirabegron; oral
9.7
80.5
176
227
F02.89*G35
ICD-10 Finland
Dementia in multiple sclerosis
812.3
76.6
74
*
2AB04
NOMESCO Finland
NA
92.6
75.6
83
10
XKD06
NOMESCO Finland
Physiologic investigation of micturition
22.0
73.4
109
57
Z01.0
ICD-10 Finland
Examination of eyes and vision
5.2
70.6
259
674
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
7.2
66.2
176
303
ZX120
NOMESCO Finland
Intravenous
7.0
65.7
177
310
XKD00
NOMESCO Finland
Uroflowmetry
7.8
65.7
164
257
G04BD04
ATC
oxybutynin; oral, transdermal
13.4
64.9
117
101
R20.2
ICD-10 Finland
Paraesthesia of skin
7.0
63.7
171
297
N06BA07
ATC
modafinil; oral
65.7
62.7
72
12
L03AB13
ATC
peginterferon beta-1a; parenteral
+∞
61.2
58
*
G36.9
ICD-10 Finland
Acute disseminated demyelination, unspecified
102.6
60.9
66
7
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
6.0
54.2
165
334
3400A
ICD-9 Finland
Multiple sclerosis[SCLEROSIS MULTIPLEX (DISSEMINATA)]
283.9
52.8
53
*
G04BD07
ATC
tolterodine; oral
11.7
49.8
95
91
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
18.8
49.6
77
45
H02AB04
ATC
methylprednisolone; systemic
4.2
48.9
216
646
UKC02
NOMESCO Finland
Cystoscopy
5.3
47.1
158
355
XKC03
NOMESCO Finland
Water cystometry
13.7
47.1
83
67
N03AX12
ATC
gabapentin; oral
4.0
45.8
213
663
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
10.0
44.9
93
104
G04BD08
ATC
solifenacin; oral
8.9
44.3
98
123
H48.1*G35
ICD-10 Finland
Retrobulbar neuritis in multiple sclerosis
+∞
43.1
41
*
N03AE01
ATC
clonazepam; systemic
6.1
42.3
123
231
4AA23
NOMESCO Finland
NA
155.0
42.2
44
*
R1250
NOMESCO Finland
Evaluation of functional capability
12.2
41.1
76
68
H53.2
ICD-10 Finland
Diplopia
12.1
39.2
73
66
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
5.9
38.5
114
218
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
27.7
38.1
52
20
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
5.5
34.9
110
226
XCW99
NOMESCO Finland
Other investigative procedure of eye
5.0
34.5
120
275
TKC22
NOMESCO Finland
Catheterisation instruction
15.9
33.6
55
37
XCD10
NOMESCO Finland
Electrophysiological examination of eye
10.7
30.2
59
59
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
86.0
30.0
33
*
G36.0
ICD-10 Finland
Neuromyelitis optica [Devic]
+∞
29.3
28
*
N05CF01
ATC
zopiclone; oral
2.6
29.3
281
1388
R4150
NOMESCO Finland
Neuropsychological rehabilitation
17.4
29.2
46
28
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
9.3
28.5
60
69
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
6.9
28.4
73
115
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
18.9
28.2
43
24
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
7.3
28.0
69
102
R35
ICD-10 Finland
Polyuria
6.1
27.6
78
139
N03AX16
ATC
pregabalin; oral
2.6
25.6
231
1088
R33
ICD-10 Finland
Retention of urine
6.4
24.8
67
113
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
4.2
23.9
96
252
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
8.0
23.5
54
72
G04BD11
ATC
fesoterodine; oral
9.2
22.9
48
55
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
12.3
22.7
41
35
J01EA01
ATC
trimethoprim; systemic
2.3
22.4
254
1332
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.7
22.1
78
180
L04AA40
ATC
cladribine; oral
+∞
22.0
21
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.9
21.6
93
260
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
12.8
21.5
38
31
R4110
NOMESCO Finland
Physiotherapy
2.4
21.2
228
1160
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
7.9
20.9
48
64
R4120
NOMESCO Finland
Occupational therapy
3.9
20.4
87
241
SPAT1229
SPAT
Assessment of need for aid
4.5
19.8
72
171
C10AC01
ATC
colestyramine; oral
6.0
18.9
53
94
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
19.3
18.7
28
15
N29
ICPC
Neurological sympt/complt other
11.0
18.6
35
33
N31.8
ICD-10 Finland
Other neuromuscular dysfunction of bladder
45.1
18.3
22
5
TKC20
NOMESCO Finland
Catheterisation of bladder
4.7
18.0
62
140
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.7
17.7
133
552
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
11.9
17.6
32
28
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.2
17.4
217
1167
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.8
17.3
123
494
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
3.8
17.2
76
217
A02BC02
ATC
pantoprazole; systemic
1.9
17.1
498
3709
RF120
NOMESCO Finland
NA
10.4
17.0
33
33
N31.1
ICD-10 Finland
Reflex neuropathic bladder, not elsewhere classified
22.4
16.9
24
11
J01CA08
ATC
pivmecillinam; oral
1.9
16.7
400
2766
L28
ICPC
Limited function/disability (L)
2.9
16.5
107
405
N03AF01
ATC
carbamazepine; oral, rectal
4.2
16.5
63
158
G50.0
ICD-10 Finland
Trigeminal neuralgia
7.5
16.2
38
53
H02AB07
ATC
prednisone; oral
2.5
16.0
135
596
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
16.1
15.8
25
16
RF410
NOMESCO Finland
NA
12.0
15.6
28
24
3773B
ICD-9 Finland
Disorders of optic nerve and visual pathways, Optic neuritis[NEURITIS RETROBULBARIS]
86.8
15.6
17
*
RF420
NOMESCO Finland
NA
9.7
15.5
31
33
G37.3
ICD-10 Finland
Acute transverse myelitis in demyelinating disease of central nervous system
163.0
15.5
16
*
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
5.6
15.5
45
84
N06AA09
ATC
amitriptyline; systemic
3.0
15.4
96
352
SPAT1215
SPAT
Assessment of need for medical rehabilitation
4.3
15.2
57
140
N30.0
ICD-10 Finland
Acute cystitis
2.5
15.0
127
562
L01BB04
ATC
cladribine; systemic
+∞
14.6
14
*
359
Kela drug reimbursment
Mirabegroni
81.6
14.6
16
*
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
11.1
14.6
27
25
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
11.1
14.6
27
25
N39.4
ICD-10 Finland
Other specified urinary incontinence
3.2
14.3
77
257
H53.1
ICD-10 Finland
Subjective visual disturbances
3.3
13.9
72
234
SPAT1231
SPAT
Assessment of adjustments needed in living environment
11.7
13.9
25
22
G04CA02
ATC
tamsulosin; oral
3.1
13.8
78
268
3419X
ICD-9 Finland
Other demyelinating diseases of central nervous system, Demyelinating disease of central nervous system, unspecified
142.3
13.5
14
*
N32.83
ICD-10 Finland
Nozzle synergy in the bladder neck
26.2
13.4
18
7
XF400
NOMESCO Finland
ECG with 12 standard connections
2.5
13.3
108
464
XKD03
NOMESCO Finland
Urethral pressure profilometry
6.5
13.3
34
54
N06AB04
ATC
citalopram; systemic
2.0
13.2
199
1140
N06AX16
ATC
venlafaxine; oral
2.1
13.1
161
847
Z50.1
ICD-10 Finland
Other physical therapy
3.7
13.0
58
167
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
23.0
12.9
18
8
A06AD11
ATC
lactulose; oral
2.8
12.5
85
331
34099
ICD-8 Finland
Multiple sclerosis
132.0
12.5
13
*
N99
ICPC
Neurological disease other
8.9
12.1
25
29
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
21.7
12.0
17
8
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
11.9
154
825
R42
ICD-10 Finland
Dizziness and giddiness
2.1
11.7
147
780
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.5
11.6
97
423
H48.1
ICD-10 Finland
Retrobulbar neuritis in diseases classified elsewhere
+∞
11.5
11
*
M03BX02
ATC
tizanidine; oral
1.7
11.5
560
4598
SPAT1216
SPAT
Assessment of functional ability
2.5
11.4
89
375
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
5.6
11.3
32
59
N04BC05
ATC
pramipexole; oral
3.1
11.0
60
203
H04.10
ICD-10 Finland
Dry eye syndrome
2.5
10.9
88
377
N03AF02
ATC
oxcarbazepine; oral
4.1
10.7
41
104
36703
ICD-8 Finland
Inflammation of optic nerve and retina, Neuritis optica, retrobulbaris
111.4
10.4
11
*
N28
ICPC
Limited function/disability (N)
7.9
10.4
23
30
N04BD01
ATC
selegiline; oral
14.8
10.0
16
11
R03CA02
ATC
ephedrine; oral
40.6
10.0
12
*
G04BDXX
ATC
NA
40.6
10.0
12
*
A06AC01
ATC
ispaghula (psylla seeds); oral
1.9
9.9
166
977
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
6.1
9.9
26
44
H47.2
ICD-10 Finland
Optic atrophy
20.3
9.8
14
7
XCK10
NOMESCO Finland
Photography of fundus of eye
2.7
9.7
65
251
G04BD10
ATC
darifenacin; oral
17.8
9.4
14
8
RS221
NOMESCO Finland
NA
5.8
9.3
25
44
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.3
9.1
44
137
G82.2
ICD-10 Finland
Paraplegia, unspecified
15.8
9.1
14
9
L04AX01
ATC
azathioprine; systemic
3.0
9.0
51
175
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
9.0
247
1691
R32
ICD-10 Finland
Unspecified urinary incontinence
5.3
9.0
26
50
G04CA01
ATC
alfuzosin; oral
3.1
9.0
47
156
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
9.0
183
1148
G51.0
ICD-10 Finland
Bell palsy
4.7
8.9
29
64
U29
ICPC
Urinary symptom/complaint other
5.0
8.7
27
56
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
7.8
8.7
19
25
U02
ICPC
Urinary frequency/urgency
2.1
8.6
101
515
M01AE01
ATC
ibuprofen; systemic, rectal
2.2
8.5
748
6936
H47.0
ICD-10 Finland
Disorders of optic nerve, not elsewhere classified
20.3
8.5
12
6
RF432
NOMESCO Finland
NA
+∞
8.3
8
*
R15
ICD-10 Finland
Faecal incontinence
5.6
8.3
23
42
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.6
8.3
61
250
U05
ICPC
Urination problems other
3.8
8.2
33
89
A28
ICPC
Limited function/disability NOS
2.5
8.2
63
265
Z43.5
ICD-10 Finland
Attention to cystostomy
33.7
8.1
10
*
H51.2
ICD-10 Finland
Internuclear ophthalmoplegia
33.7
8.1
10
*
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
33.7
8.1
10
*
SPAT1325
SPAT
Vaccination
1.7
8.0
199
1317
U04
ICPC
Incontinence urine
3.5
8.0
35
102
RS340
NOMESCO Finland
NA
13.2
7.9
13
10
N31.0
ICD-10 Finland
Uninhibited neuropathic bladder, not elsewhere classified
13.2
7.9
13
10
N02BE01
ATC
paracetamol; systemic, rectal
1.7
7.8
652
5800
U13
ICPC
Bladder symptom/complaint other
4.2
7.7
28
69
R20.0
ICD-10 Finland
Anaesthesia of skin
9.0
7.6
15
17
RF210
NOMESCO Finland
NA
3.6
7.5
32
91
KA1AE
NOMESCO Finland
Kidney ultrasound examination
4.9
7.5
23
48
H57.1
ICD-10 Finland
Ocular pain
3.0
7.5
40
136
RF312
NOMESCO Finland
NA
80.8
7.4
8
*
NA7CM
NOMESCO Finland
Spine and spinal cord extensive MRI examination with 3 Tesla magnet
80.8
7.4
8
*
F02.89
ICD-10 Finland
Dementia in another specified disease that is classified elsewhere without information of additional symptoms
80.8
7.4
8
*
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
11.0
7.3
13
12
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
9.5
7.3
14
15
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
15.9
7.2
11
7
R30.0
ICD-10 Finland
Dysuria
3.3
7.2
35
111
K59.0
ICD-10 Finland
Constipation
3.3
7.2
34
106
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.1
7.1
81
411
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
6.7
7.1
17
26
U71
ICPC
Cystitis/urinary infection other
2.5
7.0
53
222
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
6.9
162
1051
U07
ICPC
Urine symptom/complaint other
2.7
6.9
45
174
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
6.8
297
2246
A02BA02
ATC
ranitidine; systemic
1.8
6.8
117
691
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.5
6.7
492
4148
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
6.7
257
1886
K59.09
ICD-10 Finland
Constipation, unspecified
2.9
6.5
37
130
R19.5
ICD-10 Finland
Other faecal abnormalities
5.8
6.5
17
30
119
Kela drug reimbursment
Trigeminal neuralgia or glossofaryngeusneuralgia
14.4
6.4
10
7
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
8.2
6.3
13
16
WX320
NOMESCO Finland
Spinalanesthesy
0.5
6.3
53
985
G04BD01
ATC
emepronium; systemic
9.4
6.3
12
13
WW400
NOMESCO Finland
Plasmaferesis
18.2
6.3
9
5
3773A
ICD-9 Finland
Disorders of optic nerve and visual pathways, Optic neuritis[PAPILLITIS OPTICA]
+∞
6.3
6
*
34109
ICD-8 Finland
Other demyelinating diseases of central nervous system, Unspecified
+∞
6.3
6
*
TJG30
NOMESCO Finland
Anal sphincter training
+∞
6.3
6
*
G37.0
ICD-10 Finland
Diffuse sclerosis
+∞
6.3
6
*
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.5
6.2
257
1914
4AA36
NOMESCO Finland
NA
26.9
6.2
8
*
U01
ICPC
Dysuria/painful urination
2.2
6.2
59
278
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.5
6.2
44
179
N06AX21
ATC
duloxetine; oral
1.8
6.2
100
580
R13
ICD-10 Finland
Dysphagia
2.5
6.0
43
175
J01MA02
ATC
ciprofloxacin; systemic
1.5
6.0
252
1880
SPAT1262
SPAT
Handing over of treatment supplies
1.8
6.0
97
562

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
122
10
141.15
243.54
2.8
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
167
128
15.82
180.72
1.2
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
164
131
15.11
173.09
1.2
1.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
619
2257
6.68
166.22
12.0
5.8
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
749
3654
7.51
132.64
14.7
5.7
e9/l
0.5
0.5
0.12
717
3250
(3022096) Basophils/100 leukocytes in Blood
709
3301
6.57
132.48
14.3
5.9
%
0.7
0.7
1.59
698
3103
(3006315) Basophils [#/volume] in Blood
749
3668
7.46
131.60
14.7
5.8
e9/l
0.0
0.0
4.80
717
3256
(3019069) Monocytes/100 leukocytes in Blood
721
3446
6.67
129.33
14.3
6.0
%
9.4
8.0
33.11
712
3267
(3006504) Eosinophils/100 leukocytes in Blood
716
3423
6.51
127.73
14.3
5.8
%
3.1
2.8
4.38
706
3218
(3019198) Lymphocytes [#/volume] in Blood
754
3789
7.36
126.23
14.6
5.8
e9/l
1.6
2.0
2.15
726
3431
(3011412) CD3 cells [#/volume] in Blood
105
65
18.17
126.19
3.8
2.5
e9/l
1.0
1.3
1.38
55
37
(3013115) Eosinophils [#/volume] in Blood
752
3811
7.16
123.37
14.7
6.1
e9/l
0.2
0.2
0.00
723
3435
(3002030) Lymphocytes/100 leukocytes in Blood
724
3583
6.39
121.18
14.2
5.8
%
26.3
29.3
12.05
714
3387
(3018010) Neutrophils/100 leukocytes in Blood
719
3548
6.27
120.45
13.8
5.6
%
58.5
56.7
4.22
710
3362
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
90
45
22.13
119.16
2.7
2.1
%
16.8
11.4
1.94
43
24
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
82
48
18.71
100.88
4.3
2.4
e9/l
0.2
0.2
2.04
71
42
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
83
50
18.20
100.71
4.3
2.5
e6/l
404.0
536.6
0.93
71
43
(3013650) Neutrophils [#/volume] in Blood by Automated count
753
4195
6.07
99.45
15.1
8.8
e9/l
3.4
4.0
21.47
727
3707
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
152
247
7.21
92.55
1.9
1.6
iu/ml
420.1
0.0
—
5
36
(21494815) CD4 cells/100 lymphocytes in Specimen
82
63
14.23
87.24
2.6
2.1
%
51.5
38.5
—
23
8
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
71
45
17.05
83.78
2.7
2.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
341
1203
3.97
82.26
4.4
2.2
e6/l
4.6
7.9
3.59
316
1058
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
50
15
35.25
78.70
1.3
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
583
3007
3.70
77.04
2.4
2.3
nmol/l
98.3
74.9
44.97
554
2816
(3002582) Erythrocytes [#/volume] in Urine
420
1766
3.60
76.72
6.1
2.7
e6/l
15.6
50.9
2.73
369
1327
(36304419) Bacteria [Presence] in Urine
390
1607
3.53
72.78
5.1
2.5
—
—
—
0
0
(3026782) Osmolality of Urine
311
1107
3.78
72.77
4.1
2.3
mosm/kgh2o
559.1
536.1
1.01
287
959
(3030467) Casts [#/volume] in Urine by Automated count
388
1601
3.52
72.11
5.3
2.6
e6/l
0.1
0.3
3.79
330
1176
(3005719) IgG [Mass/volume] in Serum or Plasma
208
559
4.55
71.89
3.7
2.6
g/l
9.5
10.3
3.55
199
513
(3000060) B lymphocytes [#/volume] in Blood
49
22
23.51
67.24
2.8
1.9
e6/l
36.5
216.0
2.21
20
15
(3028026) IgM [Mass/volume] in Serum or Plasma
172
430
4.72
64.73
3.5
1.7
g/l
0.9
1.4
3.69
167
403
(21494814) CD8 cells/100 lymphocytes in Specimen
46
21
23.04
62.65
2.2
2.1
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
46
21
23.04
62.65
2.2
2.1
%
5.5
9.5
0.81
46
21
(3018095) Leukocytes [#/volume] in Urine
456
2218
3.16
62.24
7.2
3.1
e6/l
54.0
67.5
0.24
383
1462
(3021589) Normoblasts [#/volume] in Blood
578
3226
3.24
61.83
14.3
7.8
e9/l
0.0
0.0
0.32
526
2672
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
63
63
10.68
56.34
4.7
2.4
e6/l
920.0
683.5
1.30
38
23
(3026008) Bacteria identified in Urine by Culture
376
1731
3.02
55.02
4.7
2.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
53
44
12.74
53.49
1.2
1.1
miu/ml
1388.4
1716.3
0.90
53
44
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
250
941
3.30
51.35
4.8
2.3
e6/l
1.0
1.0
0.01
152
501
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
236
871
3.32
49.93
4.9
2.4
e6/l
5.2
3.6
0.71
138
432
(40758558) Short blood count panel - Blood
374
1806
2.84
48.88
9.7
6.3
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
683
4596
3.07
45.41
9.5
3.5
e6/l
30.0
693.4
—
9
50
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
39
25
16.27
45.39
5.5
2.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
696
4935
2.86
38.07
8.9
3.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
185
719
2.98
34.71
1.3
1.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
71
146
5.20
33.10
4.6
4.4
%
61.1
57.7
1.26
71
146
(3030905) Polymorphonuclear cells [#/volume] in Blood
70
143
5.23
32.88
4.6
4.0
e9/l
3.4
4.3
3.72
70
143
(3021440) Promyelocytes/100 leukocytes in Blood
144
542
2.98
28.26
6.1
4.4
%
0.0
0.2
4.20
29
128
(3025159) Blasts/100 leukocytes in Blood
138
516
2.98
27.36
6.1
4.4
%
0.0
0.8
0.53
28
105
(3035350) Ketones [Presence] in Urine by Test strip
528
3581
2.16
27.20
7.1
2.9
estimate
0.0
0.0
0.00
121
668
(3009261) Glucose [Presence] in Urine by Test strip
532
3629
2.15
26.86
7.1
2.9
estimate
0.0
0.0
1.06
124
657
(3017181) Myelocytes/100 leukocytes in Blood
147
575
2.86
26.82
6.0
4.3
%
0.4
1.0
2.12
30
142
(3021601) Nitrite [Presence] in Urine by Test strip
528
3593
2.15
26.80
9.6
4.1
estimate
0.0
0.0
0.38
122
685
(3002179) Metamyelocytes/100 leukocytes in Blood
139
528
2.93
26.76
5.9
4.2
%
0.1
0.7
3.07
25
102
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
37
49
7.83
26.49
3.4
2.7
%
47.1
46.1
0.08
17
12
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
29
6
49.85
24.40
1.2
1.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
22
19
11.85
21.42
2.0
2.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
62
168
3.89
20.35
1.4
2.9
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
267
1546
2.04
19.44
5.4
3.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
209
1118
2.14
18.73
1.5
1.6
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
477
3397
1.87
18.36
4.6
5.8
umol/l
9.4
10.1
1.56
460
3205
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
58
179
3.40
15.71
1.3
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
620
7236
0.53
15.68
3.0
3.4
mmol/l
1.2
1.3
0.28
571
6901
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
654
7510
0.52
15.67
3.3
3.7
mmol/l
1.5
1.5
0.43
596
7178
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
661
7534
0.53
14.49
3.3
3.7
mmol/l
4.9
4.9
0.08
616
7230
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
876
8072
5.48
13.68
17.2
8.7
u/l
27.1
26.2
1.08
868
7892
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
673
7594
0.54
13.20
3.5
3.9
mmol/l
2.9
2.9
0.19
616
7243
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
73
287
2.68
12.96
1.4
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
287
1924
1.72
12.17
11.0
4.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
264
1737
1.74
11.94
1.7
1.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
93
432
2.29
11.55
2.8
1.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
757
6642
1.92
11.06
22.3
12.7
%
13.3
13.5
3.51
750
6529
(3008757) Leukocyte morphology finding [Identifier] in Blood
23
48
4.89
10.53
3.3
3.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
249
1682
1.67
9.93
2.3
1.4
g/l
2.0
2.2
1.71
179
1113
(3041096) Erythrocytes [Presence] in Urine by Automated
298
2141
1.59
9.13
7.4
2.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
106
572
1.97
8.90
2.4
2.1
u/l
5422.8
4111.5
0.11
33
240
(1761868) Lipid panel - Serum or Plasma
244
3318
0.64
8.15
2.1
2.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
648
5621
1.56
7.84
4.7
2.9
u/l
42.2
38.7
0.55
629
5407
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
368
2853
1.49
7.63
8.4
2.9
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
33
793
0.39
6.84
2.0
1.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
817
7601
1.88
6.55
12.4
10.5
mg/l
19.1
19.2
0.03
593
5798
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
609
5299
1.47
6.51
5.3
6.9
u/l
72.4
73.7
0.49
575
5025
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
23
70
3.35
6.45
1.0
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
64
326
2.04
6.33
1.8
1.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
332
2608
1.43
6.07
3.6
3.2
u/l
27.7
29.5
0.68
320
2510
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
51
243
2.17
6.01
1.5
1.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
18
49
3.73
5.94
1.2
3.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
101
617
1.72
5.69
8.7
3.0
—
—
—
0
0
(4024509)
15
37
4.11
5.64
1.8
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
244
1843
1.45
5.40
9.5
3.2
estimate
0.0
0.0
1.08
125
675
(3004809) Band form neutrophils/100 leukocytes in Blood
23
79
2.96
5.33
2.8
2.8
%
0.5
1.3
1.67
23
60
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
5
0
+∞
5.21
1.4
0.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
293
2303
1.41
5.16
1.7
1.7
pmol/l
98.2
98.8
0.08
149
1254
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
79
1281
0.58
5.14
1.4
1.4
—
—
—
0
0
(4027681)
21
71
3.00
5.01
1.2
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
36
164
2.25
4.77
1.3
1.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
24
91
2.68
4.68
1.0
1.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
183
1357
1.44
4.39
4.1
4.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
13
35
3.75
4.37
1.1
4.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
269
2138
1.37
4.30
1.9
1.9
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
44
227
1.99
4.28
1.3
1.4
u/l
26.6
24.5
0.16
35
189
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
599
6554
0.74
4.21
3.6
4.3
mmol/mol
36.9
38.1
3.86
553
6256
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
101
1474
0.65
4.17
1.2
1.3
u/ml
1.8
10.1
5.03
42
643
(3019550) Sodium [Moles/volume] in Serum or Plasma
786
7396
1.52
4.06
11.3
10.5
mmol/l
139.9
139.6
2.69
773
7226
(3023103) Potassium [Moles/volume] in Serum or Plasma
787
7419
1.51
3.90
11.3
10.6
mmol/l
3.9
3.9
1.40
768
7229
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
35
172
2.08
3.90
1.4
1.7
e6/l
455.5
139.4
0.56
28
142
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
35
172
2.08
3.90
1.3
1.6
e6/l
11.7
10.8
0.05
28
136
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
753
7040
1.44
3.87
11.2
8.8
ml/min/173m2
96.4
91.2
11.28
641
5753
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
121
850
1.49
3.82
1.7
1.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
87
1283
0.64
3.76
1.2
1.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
24
103
2.37
3.69
1.0
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
256
2063
1.34
3.65
3.8
5.7
inr
1.1
1.1
0.06
71
687
(3000330) Specific gravity of Urine by Test strip
46
256
1.84
3.61
8.0
2.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
20
80
2.53
3.56
1.6
1.8
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
7
10
7.04
3.37
4.9
1.8
%
45.8
52.0
—
7
10
(3013826) Glucose [Moles/volume] in Serum or Plasma
427
3723
1.28
3.33
3.8
4.3
mmol/l
6.0
6.4
5.22
395
3421
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
10
28
3.60
3.20
1.5
2.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
664
7078
0.76
3.14
3.2
3.6
mmol/l
5.6
5.7
1.64
608
6686
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
752
7093
1.38
3.10
5.4
4.8
mu/l
1.7
2.1
1.03
716
6759
(3026361) Erythrocytes [#/volume] in Blood
882
8632
2.77
3.07
26.4
15.6
e12/l
4.5
4.5
1.47
877
8477
(3010813) Leukocytes [#/volume] in Blood
882
8635
2.74
3.01
26.5
15.7
e9/l
6.0
6.7
6.06
877
8472
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
216
1748
1.31
2.93
1.9
2.1
u/l
128.7
153.5
0.45
208
1665
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
75
1075
0.67
2.82
1.5
1.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
158
1230
1.35
2.80
1.4
1.4
nmol/l
21.3
20.9
0.12
136
1107
(3017732) Neutrophils [#/volume] in Blood
81
561
1.49
2.78
2.5
2.5
e9/l
3.9
4.1
0.45
71
482
(3024561) Albumin [Mass/volume] in Serum or Plasma
300
2549
1.27
2.76
4.1
4.7
g/l
37.2
37.0
0.40
274
2409
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
82
571
1.48
2.74
1.7
1.7
—
—
—
0
0
(4094501)
5
170
0.29
2.70
1.2
1.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
8
19
4.24
2.68
1.3
1.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
73
1036
0.68
2.61
1.8
1.9
—
—
—
0
0
(3008898) HLA-B27 [Presence]
23
432
0.52
2.54
1.0
1.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
82
582
1.45
2.50
1.7
1.7
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
186
1505
1.30
2.50
8.1
3.1
kg/l
1.0
1.0
0.20
25
190
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
119
1539
0.74
2.46
1.3
1.3
iu/ml
10.9
26.7
7.12
30
502
(3045414) Leukocytes [Presence] in Urine
48
305
1.61
2.44
1.7
1.6
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
63
0.00
2.43
0.0
1.1
—
—
—
0
0
(1002224) Polysomnography panel
25
448
0.55
2.39
1.1
1.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
68
471
1.48
2.36
6.0
2.4
%
1.6
1.8
0.59
61
428
(3004716) Salmonella sp identified in Stool by Organism specific culture
31
518
0.58
2.31
1.2
1.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
836
8112
1.48
2.18
12.5
9.8
—
—
—
0
0
(4035726)
33
534
0.60
2.18
1.3
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
103
781
1.36
2.18
2.2
2.5
umol/l
4.3
6.0
1.88
87
663
(3003694) ABO and Rh group [Type] in Blood
193
2302
0.79
2.14
1.6
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
606
6427
0.82
1.98
3.6
3.7
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
20
105
1.93
1.96
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
20
105
1.93
1.96
1.4
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
15
71
2.13
1.93
1.4
1.7
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
39
2.58
1.92
1.0
1.1
—
—
—
0
0
(3013512) EKG study
184
1538
1.25
1.89
3.2
2.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
44
293
1.53
1.88
1.2
2.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
21
114
1.86
1.88
14.9
3.0
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
144
1750
0.79
1.86
4.6
3.1
mmol/l
8.1
8.1
0.04
132
1538
(3014051) Protein [Presence] in Urine by Test strip
24
137
1.77
1.85
1.7
1.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
34
523
0.64
1.84
2.1
2.2
ml/min/173m2
80.9
77.3
0.18
12
206
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
27
435
0.61
1.79
1.5
1.7
mg/l
4.5
3.4
0.27
16
296
(3023520) Reticulocytes [#/volume] in Blood
46
315
1.49
1.74
2.4
2.6
e9/l
63.4
76.9
1.57
37
225
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
7
24
2.93
1.72
1.1
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
106
838
1.30
1.72
1.4
1.6
nmol/l
1095.5
1189.1
0.28
82
667
(3022621) pH of Urine by Test strip
58
417
1.42
1.72
4.8
2.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
24
393
0.60
1.71
1.7
1.9
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
576
5398
1.19
1.70
2.8
3.7
mm/h
9.1
9.3
0.26
543
5106
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
18
317
0.56
1.68
1.7
1.7
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
13
62
2.11
1.66
1.1
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
16
83
1.94
1.65
1.1
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
56
759
0.72
1.60
1.2
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
59
790
0.73
1.57
1.4
1.3
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
23
137
1.70
1.56
1.6
6.8
—
223.5
—
0
20
(3037121) Protein [Mass/volume] in Urine
30
192
1.58
1.56
4.1
3.8
g/l
0.4
0.3
0.36
12
81
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
13
64
2.05
1.54
1.2
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
44
2.29
1.53
1.0
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
11
51
2.17
1.51
2.6
1.8
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
124
1019
1.25
1.49
2.9
3.1
ng/l
717.5
287.9
0.40
68
570
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
304
3369
0.85
1.48
3.5
3.9
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
123
1482
0.80
1.48
5.0
3.3
mg/l
547.7
486.6
0.04
87
961
(3000492) Spirometry study
64
831
0.75
1.40
1.3
1.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
80
628
1.30
1.40
2.3
2.3
u/l
51.2
38.3
0.24
61
525
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
14
74
1.91
1.39
1.2
1.4
pmol/l
239.7
407.8
—
9
55
(36660697) Celiac disease serology panel - Serum
86
685
1.28
1.35
1.2
1.2
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
0
39
0.00
1.34
0.0
2.3
—
9.6
—
0
33
(4062490)
16
90
1.79
1.33
1.4
1.4
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
16
90
1.79
1.33
1.4
1.4
g/l
0.3
0.3
—
10
58
(3028192) IgG subclass 2 [Mass/volume] in Serum
16
90
1.79
1.33
1.4
1.4
g/l
2.8
2.8
—
10
57
(3027135) IgG subclass 1 [Mass/volume] in Serum
16
90
1.79
1.33
1.4
1.4
g/l
6.4
6.3
—
10
58
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
11
54
2.05
1.33
1.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
11
54
2.05
1.33
1.0
1.1
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
0
40
0.00
1.33
0.0
1.9
—
2.9
—
0
30
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
19
113
1.70
1.32
1.5
3.1
—
2577.1
—
0
11
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
59
767
0.75
1.31
1.3
1.5
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
0
41
0.00
1.31
0.0
1.2
—
564.0
—
0
34
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
9
43
2.10
1.30
1.2
1.3
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
57
740
0.75
1.26
1.9
2.1
nmol/l
315.2
372.7
1.67
52
693
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
6
25
2.41
1.24
1.0
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
6
25
2.41
1.24
1.0
1.1
%
88.2
96.9
—
6
25
(3020682) Albumin/Creatinine [Ratio] in Urine
132
1545
0.83
1.20
5.6
3.9
mg/mmol
6.5
9.6
0.64
92
993
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
26
2.32
1.19
1.3
1.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
26
2.32
1.19
1.3
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
60
465
1.31
1.18
7.3
3.2
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
33
0.00
1.16
0.0
1.6
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
0
33
0.00
1.16
0.0
25.4
—
108.0
—
0
26
(3000093) Morphology [Interpretation] in Blood Narrative
8
39
2.06
1.15
2.4
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
12
208
0.57
1.12
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
12
208
0.57
1.12
1.0
1.1
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
7
30
2.34
1.12
1.6
1.4
g/l
37.2
34.4
—
7
25
(3045424) Erythrocytes [Presence] in Urine
19
119
1.61
1.12
1.7
1.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
8
40
2.01
1.12
1.8
2.1
%
13.6
11.4
—
8
40
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
80
977
0.80
1.11
1.6
1.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
104
870
1.22
1.10
1.6
2.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
9
163
0.55
1.09
1.1
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
21
136
1.56
1.09
2.2
1.9
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
21
2.39
1.09
1.0
1.6
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
5
21
2.39
1.09
1.4
1.8
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
21
2.39
1.09
1.0
1.6
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
9
165
0.54
1.09
1.0
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
7
32
2.20
1.08
1.4
2.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
35
253
1.40
1.08
7.5
14.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
355
3823
0.88
1.07
2.7
2.8
ug/l
97.8
82.2
0.76
331
3634
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
53
410
1.31
1.07
1.2
1.3
miu/ml
163.2
236.2
0.84
21
210
(3025941) Bacteria identified in Stool by Culture
37
498
0.73
1.07
1.3
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
111
1305
0.83
1.07
1.4
1.7
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
24
348
0.68
1.06
1.1
1.4
—
—
—
0
0
(3012544) pH of Venous blood
57
447
1.29
1.05
2.5
3.8
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
21
138
1.53
1.03
1.0
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
20
131
1.54
1.00
1.0
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
29
207
1.41
0.97
1.8
1.8
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
25
351
0.70
0.95
1.1
1.4
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
0
32
0.00
0.95
0.0
2.1
—
622.3
—
0
22
(4211845)
7
37
1.90
0.94
1.4
2.8
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
68
827
0.81
0.93
1.3
1.3
iu/l
33.1
26.8
0.70
59
714
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
27
372
0.72
0.93
1.4
1.5
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
20
134
1.50
0.92
1.4
1.6
g/l
0.5
0.7
0.50
14
98
(3028433) Virus identified in Specimen by Culture
6
28
2.15
0.91
1.0
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
23
325
0.70
0.91
1.2
2.7
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
25
348
0.71
0.91
1.5
2.1
ug/l
4.8
7.2
0.49
20
323
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
11
63
1.76
0.90
1.5
2.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
6
29
2.08
0.89
1.5
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
152
0.59
0.89
1.3
1.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
149
1679
0.86
0.88
1.7
2.2
umol/l
1403.3
4633.2
1.49
136
1505
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
232
2120
1.13
0.84
2.8
2.7
ng/l
76.3
29.0
0.55
117
1015
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
171
1.41
0.83
1.3
1.8
g/l
2.5
3.0
2.88
16
145
(3050129) First trimester maternal screen panel - Serum or Plasma
39
498
0.77
0.82
1.3
1.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
312
2903
1.11
0.82
5.7
6.2
mmol/l
1.2
1.2
0.22
260
2476
(40768793) Breast Pathology biopsy report
15
225
0.66
0.82
1.2
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
36
464
0.77
0.82
1.1
1.8
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
36
463
0.77
0.81
2.9
4.3
ug/l
4.7
17.7
0.68
31
358
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
56
682
0.81
0.80
5.4
5.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
96
826
1.18
0.80
1.2
1.4
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
6
33
1.82
0.79
3.0
3.8
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
48
1.67
0.79
1.4
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
37
472
0.77
0.78
1.1
1.9
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
14
90
1.56
0.78
1.0
1.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
97
0.51
0.78
1.2
1.7
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
33
427
0.76
0.78
1.2
1.4
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
41
515
0.79
0.77
1.6
1.6
mu/l
285.6
304.8
0.21
35
461
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
33
426
0.77
0.77
1.2
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
37
470
0.78
0.76
1.1
1.9
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
34
1.77
0.76
1.0
1.1
—
—
—
0
0
(3016750) Collection duration of Urine
0
28
0.00
0.76
0.0
1.9
—
515.1
—
0
20
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
33
425
0.77
0.76
1.2
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
37
469
0.78
0.75
1.1
1.9
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
62
741
0.82
0.75
1.5
1.7
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
33
424
0.77
0.74
1.2
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
9
54
1.67
0.74
1.4
2.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
33
254
1.31
0.74
1.1
1.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
276
2566
1.11
0.73
4.8
5.5
mmol/l
1.2
1.2
0.20
248
2370
(3035285) Chloride [Moles/volume] in Venous blood
9
55
1.64
0.73
1.4
2.2
mmol/l
106.4
105.8
—
9
55
(3041354) Potassium [Moles/volume] in Venous blood
9
55
1.64
0.73
1.4
2.2
mmol/l
4.1
4.0
—
9
55
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
36
456
0.78
0.73
1.1
1.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
6
106
0.56
0.73
1.5
1.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
215
1973
1.12
0.72
1.2
1.3
u/ml
0.8
1.6
1.27
52
571
(40768806) Pleura Pathology biopsy report
5
25
2.01
0.72
1.4
1.6
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
25
2.01
0.72
6.8
2.3
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
17
117
1.46
0.72
1.4
2.0
—
1600.0
—
0
5
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
57
1.58
0.71
1.0
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
9
58
1.56
0.70
2.1
2.7
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
178
1.36
0.69
1.3
1.8
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
178
1.36
0.69
1.3
1.8
g/l
6.3
7.3
4.26
17
150
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
178
1.36
0.69
1.3
1.8
g/l
3.5
3.9
0.73
16
140
(3003338) MCHC [Mass/volume]
683
6999
0.90
0.69
23.3
13.2
g/l
332.6
332.8
0.21
683
6955
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
18
250
0.71
0.69
1.2
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
13
192
0.67
0.68
1.5
1.3
ug/g
278.0
325.0
—
6
102
(3024928) Oxygen saturation in Venous blood
15
102
1.48
0.68
2.0
3.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
28
1.79
0.66
1.2
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
13
190
0.68
0.65
1.0
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
28
360
0.77
0.65
1.1
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
29
1.73
0.64
1.2
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
20
268
0.74
0.62
1.4
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
38
467
0.81
0.62
1.4
1.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
48
398
1.22
0.62
6.0
8.3
—
—
—
0
0
(3034426) Prothrombin time (PT)
5
30
1.67
0.61
1.6
1.3
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
5
30
1.67
0.61
2.0
1.8
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
20
0.00
0.60
0.0
6.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
187
1722
1.11
0.60
3.0
3.6
ph
7.4
7.4
1.72
30
322
(4010399)
36
443
0.80
0.60
1.4
1.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
52
437
1.20
0.59
2.6
3.6
mmol/l
1.9
1.9
0.02
42
354
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
21
157
1.35
0.59
1.9
1.3
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
21
157
1.35
0.59
1.7
2.2
ug/l
191.7
258.2
0.23
21
142
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
17
123
1.39
0.58
4.1
3.3
mg/l
32.8
22.4
—
6
80
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
54
1.49
0.57
1.6
1.8
pg
32.6
32.1
—
8
54
(3029634) Reagin Ab [Titer] in Serum by VDRL
18
132
1.37
0.57
1.5
2.1
—
4.6
—
0
5
(42529406) Shigella sp [Presence] in Stool by Culture
19
252
0.75
0.57
1.2
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
169
1833
0.90
0.56
1.6
1.6
mmol/l
1.3
1.4
0.69
146
1615
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
26
203
1.29
0.56
1.7
1.8
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
89
0.56
0.56
1.2
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
80
908
0.87
0.56
1.3
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
33
266
1.25
0.56
1.3
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
36
437
0.82
0.54
1.1
1.9
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
13
182
0.71
0.54
1.8
2.8
mg/l
1.2
1.3
0.46
13
171
(40768797) Stomach Pathology biopsy report
82
925
0.88
0.53
1.2
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
96
0.62
0.52
1.2
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
19
248
0.76
0.52
1.2
1.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
40
1.50
0.51
1.7
2.9
u/ml
895.5
720.5
—
6
40
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
41
484
0.84
0.48
1.5
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
16
211
0.75
0.48
1.0
2.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
67
589
1.15
0.48
3.3
3.6
pmol/l
4.5
4.5
0.22
61
532
(3009343) pH of Capillary blood
25
310
0.80
0.47
5.5
3.0
ph
7.4
7.4
—
5
37
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
28
227
1.24
0.47
1.6
2.6
%
0.7
0.7
0.61
28
221
(3040151) Glucose [Moles/volume] in Capillary blood
7
48
1.46
0.47
6.3
8.8
mmol/l
6.3
7.2
—
7
41
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
80
715
1.13
0.45
3.7
3.5
%
30.5
31.9
0.46
62
537
(3044640) Blood type and Crossmatch panel - Blood
203
2158
0.92
0.44
2.0
2.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
10
69
1.45
0.44
1.2
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
45
522
0.85
0.44
1.7
2.3
ug/l
0.6
0.6
0.52
29
248
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
51
443
1.16
0.43
2.6
2.9
mmol/l
1.2
1.2
0.09
43
386
(3022948) Iron [Moles/volume] in Serum or Plasma
101
919
1.11
0.43
2.0
2.3
umol/l
14.7
14.3
0.17
96
856
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
14
104
1.35
0.43
1.8
4.5
u/ml
0.3
0.3
—
5
49
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
32
1.57
0.42
1.2
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
32
1.57
0.42
1.2
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
13
96
1.36
0.41
1.2
1.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
15
0.00
0.41
0.0
7.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
15
0.00
0.41
0.0
3.9
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
15
0.00
0.41
0.0
1.5
—
1.2
—
0
15
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
15
0.00
0.41
0.0
3.9
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
15
0.00
0.41
0.0
1.2
—
1.7
—
0
15
(3013293) Extractable nuclear Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
16
0.00
0.41
0.0
8.4
—
25.2
—
0
16
(3017509) Phencyclidine [Presence] in Urine
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
102
1113
0.91
0.40
1.7
2.4
ug/g
132.8
97.8
0.29
71
894
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
168
1.26
0.40
1.3
1.8
g/l
8.7
10.2
2.03
16
152
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
34
1.47
0.40
1.0
1.0
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
18
0.00
0.40
0.0
2.1
—
1.2
—
0
18
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
160
0.75
0.40
1.1
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
17
133
1.28
0.38
2.2
2.7
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
9
66
1.37
0.38
1.9
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
9
66
1.37
0.38
1.9
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
9
66
1.37
0.38
1.9
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
9
67
1.35
0.38
1.9
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
9
67
1.35
0.38
1.9
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
9
67
1.35
0.38
1.9
1.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
26
311
0.83
0.37
5.3
3.1
kpa
5.2
5.2
0.05
26
294
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
8
112
0.71
0.37
1.3
1.4
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
14
180
0.77
0.37
1.0
1.0
u/ml
2.2
3.8
—
7
62
(3024891) Influenza virus A+B Ag [Presence] in Specimen
21
256
0.82
0.36
1.3
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
88
960
0.91
0.36
2.2
2.4
mmol/l
2.4
2.4
0.18
74
845
(3005082) Progesterone [Moles/volume] in Serum or Plasma
5
80
0.62
0.35
1.6
1.3
nmol/l
36.4
32.0
—
5
64
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
126
0.71
0.35
1.2
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
29
246
1.18
0.34
2.8
2.0
iu/l
6.8
5.1
0.42
14
95
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
45
1.34
0.33
1.0
1.1
iu/ml
77.9
160.8
—
6
45
(44790047)
6
88
0.68
0.33
1.0
1.5
—
—
—
0
0
(44806118)
6
88
0.68
0.33
1.0
1.5
—
—
—
0
0
(44790048)
6
88
0.68
0.33
1.0
1.5
—
—
—
0
0
(44790049)
6
88
0.68
0.33
1.0
1.5
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
6
89
0.67
0.33
1.2
1.2
u/l
12.3
11.6
—
6
76
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
55
493
1.12
0.32
1.1
1.0
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
12
154
0.78
0.32
1.0
1.0
—
0.1
—
0
31
(4306422)
11
142
0.77
0.31
1.1
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
26
221
1.18
0.31
1.9
2.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
53
1.32
0.31
1.3
1.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
81
746
1.09
0.30
2.0
2.4
%
24.9
24.2
0.17
66
643
(40760888) Immunoglobulin light chains.free panel - Serum
11
84
1.31
0.30
1.2
3.5
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
7
55
1.27
0.30
1.0
1.2
—
2.4
—
0
5
(3038026) Centromere Ab [Units/volume] in Serum
7
56
1.25
0.29
1.0
1.2
—
95.4
—
0
5
(4034850)
20
238
0.84
0.29
9.3
7.0
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
23
270
0.85
0.29
1.2
1.4
—
8.0
—
0
7
(3009542) Hematocrit [Volume Fraction] of Blood
735
7431
0.94
0.28
19.6
11.3
%
40.5
40.4
0.30
571
6223
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
11
85
1.30
0.28
1.2
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
8
63
1.27
0.28
1.5
1.2
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
14
172
0.81
0.27
1.5
2.2
umol/l
4.5
4.8
—
9
127
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
63
687
0.91
0.27
2.3
3.1
%
21.6
21.9
0.04
20
213
(3023419) Bacteria identified in Sputum by Culture
8
65
1.23
0.27
2.8
2.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
28
243
1.16
0.27
1.1
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
5
74
0.67
0.26
1.0
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
12
149
0.80
0.26
1.0
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
9
73
1.24
0.25
1.1
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
10
126
0.79
0.24
3.5
2.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
82
0.73
0.24
1.2
1.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
48
525
0.91
0.23
11.9
11.6
inr
1.0
1.2
—
8
91
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
17
200
0.85
0.23
5.8
3.1
mmol/l
24.5
24.7
0.10
17
190
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
24
274
0.87
0.22
2.7
2.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
149
1558
0.95
0.22
1.9
2.1
mg/l
2.6
2.8
0.46
125
1362
(1001926) Buprenorphine [Presence] in Urine by Screen method
33
368
0.89
0.22
1.1
1.9
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
18
210
0.85
0.22
1.0
1.1
u/ml
4.4
5.4
—
8
102
(3023430) Cat dander IgE Ab [Units/volume] in Serum
14
167
0.84
0.21
1.0
1.1
u/ml
4.2
5.2
—
5
61
(21494890) Protein electrophoresis panel - 24 hour Urine
5
42
1.19
0.21
1.2
2.4
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
11
0.00
0.21
0.0
9.6
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
11
0.00
0.21
0.0
1.1
—
16.1
—
0
11
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
11
0.00
0.21
0.0
9.5
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
10
0.00
0.21
0.0
3.3
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
7.4
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
12
0.00
0.21
0.0
2.1
—
1.2
—
0
12
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
167
1737
0.95
0.21
1.5
1.7
mg/l
0.6
0.8
2.65
122
1288
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
12
145
0.83
0.21
1.1
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
11
89
1.24
0.21
1.2
1.4
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
27
303
0.89
0.20
1.2
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
126
1203
1.06
0.20
1.4
1.4
titre
346.7
530.8
1.54
30
249
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
14
0.00
0.20
0.0
2.6
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(44806071)
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
0
14
0.00
0.20
0.0
1.0
—
0.1
—
0
9
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
49
1.23
0.20
1.2
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
19
165
1.15
0.19
1.6
1.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
21
184
1.14
0.19
1.2
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
13
109
1.20
0.18
1.2
1.7
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
23
204
1.13
0.18
1.4
1.6
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
7
59
1.19
0.18
1.1
1.5
%
89.0
91.5
—
7
59
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
15
174
0.86
0.18
1.2
1.2
—
—
—
0
0
(44813793)
7
60
1.17
0.18
1.1
1.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
90
946
0.95
0.17
2.7
3.4
mmol/l
0.8
0.8
1.40
85
899
(3020891) Body temperature
16
184
0.87
0.17
2.3
4.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
15
129
1.17
0.17
1.2
1.2
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
5
70
0.71
0.16
1.0
1.3
—
61.9
—
0
10
(3019225) pH of Specimen
58
544
1.07
0.16
4.8
3.5
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
10
120
0.83
0.16
1.9
4.0
umol/l
29.1
33.0
—
10
106
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
12
101
1.19
0.16
1.2
1.3
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
24
215
1.12
0.16
2.0
2.3
mg/l
8.7
10.1
0.51
24
199
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
157
1623
0.96
0.16
2.0
2.0
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
44
473
0.93
0.16
1.2
1.1
—
152.5
—
0
8
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
78
0.77
0.15
1.5
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
78
0.77
0.15
1.5
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
79
0.76
0.15
1.5
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
79
0.76
0.15
1.5
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
79
0.76
0.15
1.5
1.6
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
79
0.76
0.15
1.2
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
79
0.76
0.15
1.5
1.6
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
55
517
1.07
0.15
6.8
9.7
mmol/l
1.0
1.0
0.02
40
396
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
18
159
1.13
0.15
1.2
1.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
110
1057
1.05
0.15
2.1
2.8
ng/l
599.6
632.6
0.06
88
859
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
24
265
0.90
0.15
1.5
1.4
pmol/l
69.2
103.9
0.39
24
259
(3007853) Bacteria identified in Skin by Aerobe culture
83
792
1.05
0.15
1.5
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
28
306
0.91
0.14
1.7
1.9
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
7
86
0.81
0.14
1.4
1.6
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
213
2081
1.03
0.13
2.1
2.5
u/l
53.4
55.2
0.49
202
1957
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
18
161
1.12
0.13
1.4
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
50
529
0.94
0.12
1.2
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
36
336
1.07
0.12
1.7
1.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
79
758
1.05
0.12
1.3
1.2
iu/ml
218.1
155.2
0.44
33
306
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
12
137
0.87
0.12
1.0
1.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
11
95
1.16
0.11
3.7
2.1
%
16.1
16.8
—
6
50
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
26
240
1.09
0.11
7.8
9.9
mmol/l
24.3
24.0
0.20
26
233
(3019060) Gas panel - Arterial blood
30
279
1.08
0.11
5.3
8.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
305
3097
0.98
0.11
1.9
1.9
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
18
163
1.11
0.11
1.2
1.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
33
309
1.07
0.10
2.1
2.6
ng/l
78.9
88.3
0.15
27
268
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
140
1436
0.97
0.10
1.7
1.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
200
2040
0.97
0.10
1.5
1.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
12
106
1.13
0.10
3.8
2.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
126
1228
1.03
0.09
1.4
1.5
pmol/l
446.4
38649080.9
1.81
114
1110
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
5
47
1.06
0.09
9.6
3.3
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
5
47
1.06
0.09
1.0
1.4
u/l
7.2
6.5
—
5
39
(3022313) Gas panel - Capillary blood
20
217
0.92
0.09
5.2
3.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
206
2025
1.02
0.08
1.5
1.5
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
6
57
1.05
0.08
1.2
1.5
ug/l
3.3
5.9
—
6
47
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
58
1.03
0.08
1.2
1.4
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
10
113
0.88
0.08
1.0
1.4
—
23.3
—
0
7
(3032773) Endomysium IgG Ab [Titer] in Serum
10
88
1.14
0.08
1.2
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
6
72
0.83
0.07
1.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
157
1599
0.98
0.07
1.8
2.0
—
—
—
0
0
(4281824)
7
80
0.87
0.07
1.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
9
84
1.07
0.07
1.2
1.4
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
30
316
0.95
0.07
1.2
1.3
u/l
12.5
11.5
0.15
24
259
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
94
0.85
0.06
1.6
1.4
—
—
—
0
0
(4268621)
11
99
1.11
0.06
2.3
2.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
15
162
0.92
0.06
2.6
1.9
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
12
131
0.91
0.05
2.3
3.7
mmol/l
4.0
3.7
0.76
12
124
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
10
90
1.11
0.05
1.1
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
30
287
1.05
0.05
1.4
2.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
43
416
1.04
0.05
4.1
3.8
ng/l
77.4
78.3
0.02
36
387
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
18
169
1.07
0.05
1.3
1.1
u/ml
0.7
2.4
—
6
90
(3038177) Helicobacter pylori Ab [Presence] in Serum
18
169
1.07
0.05
1.1
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
120
0.92
0.05
1.2
1.4
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
22
231
0.95
0.04
1.1
1.3
—
2.7
—
0
27
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
18
170
1.06
0.04
1.3
1.2
u/ml
303.1
252.4
—
10
108
(3044889) 12 lead EKG panel
476
4739
1.01
0.04
2.7
2.9
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
64
628
1.02
0.03
1.2
1.3
u/ml
75.9
190.9
3.49
57
581
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
33
321
1.03
0.02
1.7
1.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
87
859
1.01
0.02
2.7
3.2
ug/l
1.4
1.4
0.12
80
793
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
10
93
1.08
0.02
1.5
2.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
12
113
1.06
0.02
2.7
2.6
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
207
2081
0.99
0.01
2.5
3.3
mmol/l
2.3
2.3
0.03
183
1899
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
616
6150
1.01
0.01
4.6
4.2
pmol/l
14.4
14.3
0.41
570
5818
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
10
96
1.04
0.00
1.3
1.4
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
22
222
0.99
0.00
4.2
2.3
g/l
3.1
3.5
0.72
22
211
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
103
0.97
0.00
1.5
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
10
103
0.97
0.00
1.2
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
39
395
0.99
0.00
1.5
1.8
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
7
0.00
0.00
0.0
5.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
51
0.98
0.00
1.2
1.4
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
51
0.98
0.00
2.2
7.8
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
56
560
1.00
0.00
2.4
2.6
—
—
—
0
0
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
7
72
0.97
0.00
4.9
3.3
u/ml
17.0
50.4
—
7
72
(3051101) Glucose [Moles/volume] in Cord blood
0
8
0.00
0.00
0.0
2.9
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.8
—
3.4
—
0
5
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
50
1.00
0.00
2.0
2.0
—
—
—
0
0
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
4.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
56
0.89
0.00
1.0
1.1
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
4.0
—
0
6
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
0
6
0.00
0.00
0.0
3.3
—
28.5
—
0
6
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
17.8
—
0
5
(3009677) Dengue virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
59
1.02
0.00
1.0
1.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
6
0.00
0.00
0.0
4.3
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4038314)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
57
0.88
0.00
1.0
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
9
92
0.98
0.00
1.0
1.2
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
4.6
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
64
0.94
0.00
2.2
1.5
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.3
—
39.7
—
0
6
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
71
0.99
0.00
1.0
1.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
9
0.00
0.00
0.0
11.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
57
0.88
0.00
1.2
1.7
—
—
—
0
0
(3018840) Calcitonin [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
7
77
0.91
0.00
5.0
2.4
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: MSMED_INTERFERONBETA1A – Use of interferon beta-1a

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).